Resveratrol Affects ccRCC Cell Senescence and Macrophage Polarization by Regulating the Stability of CCNB1 by RBM15

References

• Xi W , ChenX , SunJet al. Combined treatment with valproic acid and 5-Aza-2′-deoxycytidine synergistically inhibits human clear cell renal cell carcinoma growth and migration. Med. Sci. Monit.24, 1034–1043 (2018).
   PubMed Web of Science ®Google Scholar
• Rausch M , WeissA , ZoetemelkMet al. Optimized combination of HDACI and TKI efficiently inhibits metabolic activity in renal cell carcinoma and overcomes sunitinib resistance. Cancers (Basel).12(11), (2020).
   PubMed Web of Science ®Google Scholar
• Jiang N , NiuG , PanYHet al. CBX4 transcriptionally suppresses KLF6 via interaction with HDAC1 to exert oncogenic activities in clear cell renal cell carcinoma. EBioMedicine.53, 102692 (2020).
   PubMed Web of Science ®Google Scholar
• Chen J , RenJJ , CaiJ , WangX. Efficacy and safety of HDACIs in the treatment of metastatic or unresectable renal cell carcinoma with a clear cell phenotype: a systematic review and meta-analysis. Medicine (Baltimore).100(31), e26788 (2021).
   PubMed Web of Science ®Google Scholar
• He L , LiH , WuAet al. Functions of N6-methyladenosine and its role in cancer. Mol. Cancer18(1), 176 (2019).
   PubMed Web of Science ®Google Scholar
• Liu L , LiH , HuDet al. Insights into N6-methyladenosine and programmed cell death in cancer. Mol. Cancer21(1), 32 (2022).
   PubMed Web of Science ®Google Scholar
• Wang S , GaoS , ZengYet al. N6-methyladenosine reader YTHDF1 promotes ARHGEF2 translation and RhoA signaling in colorectal cancer. Gastroenterology162(4), 1183–1196 (2022).
   PubMed Web of Science ®Google Scholar
• Wang T , KongS , TaoM , JuS. The potential role of RNA N6-methyladenosine in cancer progression. Mol. Cancer.19(1), 88 (2020).
   PubMed Web of Science ®Google Scholar
• Ren B , KwahMX , LiuCet al. Resveratrol for cancer therapy: challenges and future perspectives. Cancer Lett.515, 63–72 (2021).
   PubMed Web of Science ®Google Scholar
• Carter LG , D’orazioJA , PearsonKJ. Resveratrol and cancer: focus on in vivo evidence. Endocr. Relat. Cancer.21(3), R209–225 (2014).
   PubMed Web of Science ®Google Scholar
• Zaffaroni N , BerettaGL. Resveratrol and Prostate Cancer: The Power of Phytochemicals. Curr Med Chem.28(24), 4845–4862 (2021).
   PubMed Web of Science ®Google Scholar
• Gu YR , KimJ , NaJC , HanWK. Mitochondrial metabolic reprogramming by SIRT3 regulation ameliorates drug resistance in renal cell carcinoma. PLOS ONE17(6), e0269432 (2022).
   PubMed Web of Science ®Google Scholar
• Galiniak S , AebisherD , Bartusik-AebisherD. Health benefits of resveratrol administration. Acta Biochim. Pol.66(1), 13–21 (2019).
   PubMed Web of Science ®Google Scholar
• Rauf A , ImranM , ButtMSet al. Resveratrol as an anti-cancer agent: a review. Crit. Rev. Food Sci. Nutr.58(9), 1428–1447 (2018).
   PubMed Web of Science ®Google Scholar
• Yue B , SongC , YangLet al. METTL3-mediated N6-methyladenosine modification is critical for epithelial-mesenchymal transition and metastasis of gastric cancer. Mol. Cancer.18(1), 142 (2019).
   PubMed Web of Science ®Google Scholar
• Zeng X , ChenK , LiLet al. Epigenetic activation of RBM15 promotes clear cell renal cell carcinoma growth, metastasis and macrophage infiltration by regulating the m6A modification of CXCL11. Free Radic. Biol. Med.184, 135–147 (2022).
   PubMed Web of Science ®Google Scholar
• Bian Y , WangX , ZhengZet al. Resveratrol drives cancer cell senescence via enhancing p38MAPK and DLC1 expressions. Food Funct.13(6), 3283–3293 (2022).
   PubMed Web of Science ®Google Scholar
• Ma F , MaY , LiuKet al. Resveratrol induces DNA damage-mediated cancer cell senescence through the DLC1-DYRK1A-EGFR axis. Food Funct.14(3), 1484–1497 (2023).
   PubMed Web of Science ®Google Scholar
• Zhang H , ZhangX , LiXet al. Effect of CCNB1 silencing on cell cycle, senescence, and apoptosis through the p53 signaling pathway in pancreatic cancer. J. Cell Physiol.234(1), 619–631 (2018).
   PubMed Web of Science ®Google Scholar
• Yang D , GuoQ , LiangYet al. Wogonin induces cellular senescence in breast cancer via suppressing TXNRD2 expression. Arch Toxicol.94(10), 3433–3447 (2020).
   PubMed Web of Science ®Google Scholar
• Vicente R , Mausset-BonnefontAL , JorgensenCet al. Cellular senescence impact on immune cell fate and function. Aging Cell.15(3), 400–406 (2016).
   PubMed Web of Science ®Google Scholar
• Lu L , LiY , WenH , FengC. Overexpression of miR-15b promotes resistance to sunitinib in renal cell carcinoma. J. Cancer.10(15), 3389–3396 (2019).
   PubMed Web of Science ®Google Scholar
• Ansari MSZ , StagniV , IuzzolinoAet al. Pharmacological targeting of CBP/p300 drives a redox/autophagy axis leading to senescence-induced growth arrest in non-small cell lung cancer cells. Cancer Gene Ther. doi: 10.1038/s41417-022-00524-8 (2022).
   PubMed Web of Science ®Google Scholar
• Feng Y , WangX , XuLet al. The transcription factor ZBP-89 suppresses p16 expression through a histone modification mechanism to affect cell senescence. Febs J.276(15), 4197–4206 (2009).
   PubMed Web of Science ®Google Scholar
• Birch J , GilJ. Senescence and the SASP: many therapeutic avenues. Genes Dev.34(23–24), 1565–1576 (2020).
   PubMed Web of Science ®Google Scholar
• Cuollo L , AntonangeliF , SantoniA , SorianiA. The senescence-associated secretory phenotype (SASP) in the challenging future of cancer therapy and age-related diseases. Biology (Basel).9(12), (2020).
   PubMedGoogle Scholar
• He S , SharplessNE. Senescence in health and disease. Cell169(6), 1000–1011 (2017).
   PubMed Web of Science ®Google Scholar
• Liu Y , YangS , WangKet al. Cellular senescence and cancer: Focusing on traditional Chinese medicine and natural products. Cell Prolif.53(10), e12894 (2020).
   PubMed Web of Science ®Google Scholar
• Mabrouk N , GhioneS , LaurensVet al. Senescence and Cancer: Role of Nitric Oxide (NO) in SASP. Cancers (Basel).12(5), (2020).
   PubMed Web of Science ®Google Scholar
• Takasugi M , YoshidaY , OhtaniN. Cellular senescence and the tumour microenvironment. Mol. Oncol.16(18), 3333–3351 (2022).
   PubMed Web of Science ®Google Scholar
• Wang B , KohliJ , DemariaM. Senescent cells in cancer therapy: friends or foes?Trends Cancer6(10), 838–857 (2020).
   PubMed Web of Science ®Google Scholar
• Sun H , WangH , WangXet al. Aurora-A/SOX8/FOXK1 signaling axis promotes chemoresistance via suppression of cell senescence and induction of glucose metabolism in ovarian cancer organoids and cells. Theranostics10(15), 6928–6945 (2020).
   PubMed Web of Science ®Google Scholar
• Wang Y , ChenY , GuanLet al. Carnitine palmitoyltransferase 1C regulates cancer cell senescence through mitochondria-associated metabolic reprograming. Cell Death Differ.25(4), 735–748 (2018).
   PubMed Web of Science ®Google Scholar
• Chen KY , ChenCC , ChangYC , ChangMC. Resveratrol induced premature senescence and inhibited epithelial-mesenchymal transition of cancer cells via induction of tumor suppressor Rad9. PLOS ONE14(7), e0219317 (2019).
   PubMed Web of Science ®Google Scholar
• Farhadnejad H , EmamatH , ZandH. The effect of resveratrol on cellular senescence in normal and cancer cells: focusing on cancer and age-related diseases. Nutr Cancer71(7), 1175–1180 (2019).
   PubMed Web of Science ®Google Scholar
• Li YR , LiS , LinCC. Effect of resveratrol and pterostilbene on aging and longevity. Biofactors.44(1), 69–82 (2018).
   PubMed Web of Science ®Google Scholar
• Pyo IS , YunS , YoonYEet al. Mechanisms of aging and the preventive effects of resveratrol on age-related diseases. Molecules25(20), (2020).
   PubMed Web of Science ®Google Scholar
• Chen EB , QinX , PengKet al. HnRNPR-CCNB1/CENPF axis contributes to gastric cancer proliferation and metastasis. Aging (Albany NY).11(18), 7473–7491 (2019).
   PubMedGoogle Scholar
• Xia P , ZhangH , XuKet al. MYC-targeted WDR4 promotes proliferation, metastasis, and sorafenib resistance by inducing CCNB1 translation in hepatocellular carcinoma. Cell Death Dis.12(7), 691 (2021).
   PubMed Web of Science ®Google Scholar
• Zou Y , RuanS , JinLet al. CDK1, CCNB1, and CCNB2 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma. Med. Sci. Monit.26, e925289 (2020).
   PubMed Web of Science ®Google Scholar
• Shen L , KangL , WangDet al. Legumain-deficient macrophages promote senescence of tumor cells by sustaining JAK1/STAT1 activation. Cancer Lett.472, 40–49 (2020).
   PubMed Web of Science ®Google Scholar